Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Microbiol Resour Announc ; 9(42)2020 Oct 15.
Article in English | MEDLINE | ID: mdl-33060267

ABSTRACT

We report the draft genome sequence of a novel member of the order Picornavirales that was obtained from the gills of farmed Japanese eel (Anguilla japonica). A putative polyprotein encoded by the genome was similar to that of other picornaviruses and shared 31% amino acid identity with that of eel picornavirus 1.

2.
Phys Rev Lett ; 125(11): 111104, 2020 Sep 11.
Article in English | MEDLINE | ID: mdl-32975998

ABSTRACT

The no-hair theorem by Mayo and Bekenstein states that there exists no nonextremal static and spherical charged black hole endowed with hair in the form of a charged scalar field with a self-interaction potential. In our recent work [Phys. Lett. B 803, 135324 (2020)PYLBAJ0370-2693], we showed that the effect of a scalar mass term is important at an asymptotic infinity, which was omitted to prove the no-hair theorem. In this Letter, we demonstrate that there actually exists static and spherical charged scalar hair, dubbed as Q hair, around charged black holes, by taking into account the backreaction to the metric and gauge field. We also discuss that Q cloud, which is constructed without the backreaction around a Reissner-Nordström black hole, is a good approximation to Q hair under a certain limit.

3.
J High Energy Phys ; 2020(9): 54, 2020.
Article in English | MEDLINE | ID: mdl-32921971

ABSTRACT

In our previous work, we found new types of the cosmic string solutions in the Abelian-Higgs model with an enhanced U(1) global symmetry. We dubbed those solutions as the compensated/uncompensated strings. The compensated string is similar to the conventional cosmic string in the Abrikosov-Nielsen-Olesen (ANO) string, around which only the would-be Nambu-Goldstone (NG) boson winds. Around the uncompensated string, on the other hand, the physical NG boson also winds, where the physical NG boson is associated with the spontaneous breaking of the enhanced symmetry. Our previous simulation in the 2+1 dimensional spacetime confirmed that both the compensated/uncompensated strings are formed at the phase transition of the symmetry breaking. Non-trivial winding of the physical NG boson around the strings potentially causes the so-called axion domain- wall problem when the model is applied to the axion model. In this paper, we perform simulation in the 3+1 dimensional spacetime to discuss the fate of the uncompensated strings. We observe that the evolution of the string-network is highly complicated in the 3+1 dimensional simulation compared with that seen in the previous simulation. Despite such complications, we find that the number of the uncompensated strings which could cause can be highly suppressed at late times. Our observation suggests that the present setup can be applied to the axion model without suffering from the axion domain-wall problem.

4.
J High Energy Phys ; 2020(7): 48, 2020.
Article in English | MEDLINE | ID: mdl-32834719

ABSTRACT

In this paper, we show that the Peccei-Quinn (PQ) symmetry with a good quality can be realized in a simple B -L extension of the minimal supersymmetric standard model. The PQ symmetry is a remnant of the B - L gauge symmetry at the renormalizable level. Besides, the sufficient quality of the PQ symmetry is preserved by a non anomalous discrete gauged R-symmetry and a small gravitino mass m 3/2 ≪ 100 GeV. A viable mass range is m 3 / 2 = O 1 eV which allows a high reheating temperature and many baryogenesis scenarios typified by the thermal leptogenesis without any astrophysical and cosmological problems. Such a light gravitino may be tested in the future 21cm line observations.

5.
Jpn J Ophthalmol ; 62(6): 699-705, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30324322

ABSTRACT

PURPOSE: Enterococcus faecalis causes severe acute endophthalmitis and often leads to poor visual outcomes. Conjunctival bacterial cultures occasionally grow atypical bacteria including E. faecalis, which can potentially contribute to the development of postoperative endophthalmitis. However, the characteristics of these ocular E. faecalis strains are unknown. This study is the first attempt to determine the population characteristics of E. faecalis clinical isolates from eye infections and ocular commensals. STUDY DESIGN: Retrospective METHODS: Twenty-eight E. faecalis ocular isolates were collected from 23 patients at 3 referring hospitals. The multilocus sequence typing (MLST) data were analyzed using the eBURST program. Phenotypes of cytolysin and gelatinase, antibiotic susceptibility, and mutations of the quinolone resistance-determining regions (QRDRs) of gyrA and parC were also examined. Pulsed-field gel electrophoresis (PFGE) was performed for strains from the same patients. RESULTS: PFGE revealed that 3 patients retained identical strains for 10 months to 2 and a half years. MLST identified 12 sequence types (STs), which were clustered into 3 clonal complexes (CCs) and 8 singletons, with ST179 the largest. Thirteen of the 23 isolates (56.5%) belonged to CC58, CC8, or CC2, which have previously been reported to be major CCs. Six of the 23 strains (26.0%) exhibited high-level quinolone resistance derived from mutations of the QRDRs in both gyrA and parC. CONCLUSIONS: The sequence types of E. faecalis ocular isolates were divergent, with no eye-specific lineages observed. Persistent colonization of E. faecalis on the ocular surface was demonstrated in patients with chronic ocular surface diseases.


Subject(s)
DNA, Bacterial/analysis , Endophthalmitis/microbiology , Enterococcus faecalis/genetics , Eye Infections, Bacterial/microbiology , Gram-Positive Bacterial Infections/microbiology , Aged , Aged, 80 and over , Conjunctiva/microbiology , Conjunctiva/pathology , Electrophoresis, Gel, Pulsed-Field , Endophthalmitis/diagnosis , Enterococcus faecalis/isolation & purification , Eye Infections, Bacterial/diagnosis , Female , Genetic Variation , Gram-Positive Bacterial Infections/diagnosis , Humans , Male , Middle Aged , Multilocus Sequence Typing , Polymerase Chain Reaction , Retrospective Studies
7.
BMC Oral Health ; 16: 40, 2016 Mar 22.
Article in English | MEDLINE | ID: mdl-27001253

ABSTRACT

BACKGROUND: Dental plaque formed on tooth surfaces is a complex ecosystem composed of diverse oral bacteria and salivary components. Accumulation of dental plaque is a risk factor for dental caries and periodontal diseases. L-arginine has been reported to decrease the risk for dental caries by elevating plaque pH through the activity of arginine deiminase in oral bacteria. Here we evaluated the potential of L-arginine to remove established oral biofilms. METHODS: Biofilms were formed using human saliva mixed with Brain Heart Infusion broth supplemented with 1 % sucrose in multi-well plates or on plastic discs. After washing the biofilms with saline, citrate (10 mM, pH3.5), or L-arginine (0.5 M, pH3.5), the retained biofilms were analyzed by crystal violet staining, scanning electron microscopy, and Illumina-based 16S rDNA sequencing. RESULTS: Washing with acidic L-arginine detached oral biofilms more efficiently than saline and significantly reduced biofilm mass retained in multi-well plates or on plastic discs. Illumina-based microbiota analysis showed that citrate (pH3.5) preferentially washed out Streptococcus from mature oral biofilm, whereas acidic L-arginine prepared with 10 mM citrate buffer (pH3.5) non-specifically removed microbial components of the oral biofilm. CONCLUSIONS: Acidic L-arginine prepared with citrate buffer (pH3.5) effectively destabilized and removed mature oral biofilms. The acidic L-arginine solution described here could be used as an additive that enhances the efficacy of mouth rinses used in oral hygiene.


Subject(s)
Arginine/pharmacology , Biofilms/drug effects , Dental Plaque/prevention & control , Dental Caries/prevention & control , Humans , Saliva
8.
PLoS One ; 11(2): e0148887, 2016.
Article in English | MEDLINE | ID: mdl-26859882

ABSTRACT

Phase changes in Bacteroides fragilis, a member of the human colonic microbiota, mediate variations in a vast array of cell surface molecules, such as capsular polysaccharides and outer membrane proteins through DNA inversion. The results of the present study show that outer membrane vesicle (OMV) formation in this anaerobe is also controlled by DNA inversions at two distantly localized promoters, IVp-I and IVp-II that are associated with extracellular polysaccharide biosynthesis and the expression of outer membrane proteins. These promoter inversions are mediated by a single tyrosine recombinase encoded by BF2766 (orthologous to tsr19 in strain NCTC9343) in B. fragilis YCH46, which is located near IVp-I. A series of BF2766 mutants were constructed in which the two promoters were locked in different configurations (IVp-I/IVp-II = ON/ON, OFF/OFF, ON/OFF or OFF/ON). ON/ON B. fragilis mutants exhibited hypervesiculating, whereas the other mutants formed only a trace amount of OMVs. The hypervesiculating ON/ON mutants showed higher resistance to treatment with bile, LL-37, and human ß-defensin 2. Incubation of wild-type cells with 5% bile increased the population of cells with the ON/ON genotype. These results indicate that B. fragilis regulates the formation of OMVs through DNA inversions at two distantly related promoter regions in response to membrane stress, although the mechanism underlying the interplay between the two regions controlled by the invertible promoters remains unknown.


Subject(s)
Bacterial Outer Membrane Proteins/biosynthesis , Bacteroides fragilis/metabolism , Sequence Inversion/genetics , Anti-Bacterial Agents/pharmacology , Bacteroides fragilis/drug effects , Bacteroides fragilis/physiology , Cell Membrane/metabolism , Drug Resistance, Bacterial , Extracellular Vesicles/metabolism , Extracellular Vesicles/physiology , Gene Expression Regulation, Bacterial/genetics , Gene Expression Regulation, Bacterial/physiology , Promoter Regions, Genetic/genetics , Promoter Regions, Genetic/physiology , Proteomics , Sequence Inversion/physiology
9.
J Bacteriol ; 194(13): 3464-74, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22544268

ABSTRACT

Clostridium difficile is an important, emerging nosocomial pathogen. The transition from harmless colonization to disease is typically preceded by antimicrobial therapy, which alters the balance of the intestinal flora, enabling C. difficile to proliferate in the colon. One of the most perplexing aspects of the C. difficile infectious cycle is its ability to survive antimicrobial therapy and transition from inert colonization to active infection. Toxin-antitoxin (TA) systems have been implicated in facilitating persistence after antibiotic treatment. We identified only one TA system in C. difficile strain 630 (epidemic type X), designated MazE-cd and MazF-cd, a counterpart of the well-characterized Escherichia coli MazEF TA system. This E. coli MazF toxin cleaves mRNA at ACA sequences, leading to global mRNA degradation, growth arrest, and death. Likewise, MazF-cd expression in E. coli or Clostridium perfringens resulted in growth arrest. Primer extension analysis revealed that MazF-cd cleaved RNA at the five-base consensus sequence UACAU, suggesting that the mRNAs susceptible to cleavage comprise a subset of total mRNAs. In agreement, we observed differential cleavage of several mRNAs by MazF-cd in vivo, revealing a direct correlation between the number of cleavage recognition sites within a given transcript and its susceptibility to degradation by MazF-cd. Interestingly, upon detailed statistical analyses of the C. difficile transcriptome, the major C. difficile virulence factor toxin B (TcdB) and CwpV, a cell wall protein involved in aggregation, were predicted to be significantly resistant to MazF-cd cleavage.


Subject(s)
Bacterial Toxins/metabolism , Clostridioides difficile/metabolism , Endoribonucleases/metabolism , RNA, Messenger/metabolism , Antitoxins/genetics , Antitoxins/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Bacterial Toxins/genetics , Base Sequence , Clostridioides difficile/genetics , Endoribonucleases/genetics , Humans , Molecular Sequence Data , RNA, Messenger/genetics , Substrate Specificity
10.
Protein Expr Purif ; 76(1): 83-9, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20940055

ABSTRACT

Clostripain (CLO) produced by Clostridium histolyticum is an arginine-specific endopeptidase with the potential for applicability to diverse medical and industrial uses. In this study, we developed an expression system allowing high-level production and efficient purification of recombinant CLO (rCLO). Our expression system comprises pCLO, an rCLO expressing vector, and Clostridium perfringens 13Δ6, an in-frame deletion strain as to six genes encoding major virulence factors and secretory proteins. rCLO was purified from the culture supernatant of C. perfringens 13Δ6/pCLO by ammonium sulfate precipitation, hydroxyapatite chromatography, and affinity chromatography on benzamidine-Sepharose. From 200 ml of culture supernatant 4.5 mg of purified rCLO was obtained. N-Terminal amino acid sequencing and molecular mass determination of the purified rCLO and commercially available CLO revealed that the two enzymes have identical subunits, a 38.1-kDa heavy chain and a 15.0-kDa light chain, indicating that rCLO is processed in the same manner as CLO. Analysis of the enzymatic activities toward N-benzoyl-L-arginine p-nitroanilide and acyl-L-lysine p-nitroanilide showed that rCLO and CLO exhibit strict specificity for arginine at the P1 position, and that the specific activity of the former is approximately 2-fold higher than that of the latter. These results indicate that the new method involving a virulence-attenuated C. perfringens strain is useful for preparing large amounts of high-grade rCLO.


Subject(s)
Clostridium perfringens/metabolism , Cysteine Endopeptidases/biosynthesis , Recombinant Proteins/biosynthesis , Amino Acid Sequence , Chromatography, Affinity , Clostridium perfringens/genetics , Clostridium perfringens/pathogenicity , Cysteine Endopeptidases/isolation & purification , Recombinant Proteins/isolation & purification , Virulence
11.
Appl Environ Microbiol ; 77(4): 1375-82, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21183644

ABSTRACT

Many pathogenic clostridial species produce toxins and enzymes. To facilitate genome-wide identification of virulence factors and biotechnological application of their useful products, we have developed a markerless in-frame deletion method for Clostridium perfringens which allows efficient counterselection and multiple-gene disruption. The system comprises a galKT gene disruptant and a suicide galK plasmid into which two fragments of a target gene for in-frame deletion are cloned. The system was shown to be accurate and simple by using it to disrupt the alpha-toxin gene of the organism. It was also used to construct of two different virulence-attenuated strains, ΗΝ1303 and HN1314: the former is a disruptant of the virRS operon, which regulates the expression of virulence factors, and the latter is a disruptant of the six genes encoding the α, θ, and κ toxins; a clostripain-like protease; a 190-kDa secretory protein; and a putative cell wall lytic endopeptidase. Comparison of the two disruptants in terms of growth ability and the background levels of secreted proteins showed that HN1314 is more useful than ΗΝ1303 as a host for the large-scale production of recombinant proteins.


Subject(s)
Bacterial Toxins/genetics , Calcium-Binding Proteins/genetics , Clostridium perfringens/genetics , Sequence Deletion , Type C Phospholipases/genetics , Virulence Factors/genetics , Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Bacterial Toxins/biosynthesis , Base Sequence , Blotting, Northern , Calcium-Binding Proteins/biosynthesis , Clostridium perfringens/enzymology , Clostridium perfringens/metabolism , Clostridium perfringens/pathogenicity , Electrophoresis, Polyacrylamide Gel , Hemolysin Proteins/biosynthesis , Hemolysin Proteins/genetics , Microbial Collagenase/biosynthesis , Microbial Collagenase/genetics , Mutagenesis , Plasmids , Reading Frames , Recombinant Proteins/biosynthesis , Recombinant Proteins/metabolism , Sequence Analysis, Protein , Type C Phospholipases/biosynthesis , Virulence/genetics , Virulence Factors/metabolism
12.
Microbiology (Reading) ; 156(Pt 2): 561-569, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19850615

ABSTRACT

Clostridium perfringens produces a homologue of clostripain (Clo), the arginine-specific endopeptidase of Clostridium histolyticum. To determine the biochemical and biological properties of the C. perfringens homologue (Clp), it was purified from the culture supernatant of a recombinant C. perfringens strain by cation-exchange chromatography and ultrafiltration. Analysis by SDS-PAGE, N-terminal amino acid sequencing and TOF mass spectrometry revealed that Clp consists of two polypeptides comprising heavy (38 kDa) and light (16 kDa or 15 kDa) chains, and that the two light chains differ in the N-terminal cleavage site. This difference in the light chain did not affect the enzymic activity toward N-benzoyl-l-arginine p-nitroanilide (Bz-l-arginine pNA), as demonstrated by assaying culture supernatants differing in the relative ratio of the two light chains. Although the purified Clp preferentially degraded Bz-dl-arginine pNA rather than Bz-dl-lysine pNA, it degraded the latter more efficiently than did Clo. Clp showed 2.3-fold higher caseinolytic activity than Clo, as expected from the difference in substrate specificity. Clp caused an increase in vascular permeability when injected intradermally into mice, implying a possible role of Clp in the pathogenesis of clostridial myonecrosis.


Subject(s)
Clostridium perfringens/enzymology , Endopeptidase Clp/isolation & purification , Amino Acid Sequence , Animals , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , Capillary Permeability/drug effects , Cloning, Molecular , Clostridium perfringens/genetics , Clostridium perfringens/metabolism , Cysteine Endopeptidases/genetics , Cysteine Endopeptidases/isolation & purification , Cysteine Endopeptidases/metabolism , Electrophoresis, Polyacrylamide Gel , Endopeptidase Clp/genetics , Endopeptidase Clp/metabolism , Male , Mice , Molecular Sequence Data , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism
13.
Appl Microbiol Biotechnol ; 80(4): 627-35, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18629492

ABSTRACT

Clostridium histolyticum collagenase is used to isolate cells from various organs and tissues for tissue engineering, and also to treat destructive fibrosis; thus, the demand for high-grade enzyme preparations is increasing. In this study, we constructed a plasmid encoding C. histolyticum type II collagenase (ColH) with a C-terminal hexahistidine tag (ColH-his) to facilitate the purification of the enzyme through immobilized metal affinity chromatography (IMAC). When ColH-his was expressed in a protease-deficient mutant of Clostridium perfringens, it was produced in the culture supernatant more efficiently than the untagged ColH. ColH-his exhibited the same hydrolytic activity as ColH against 4-phenylazobenzyloxy-carbonyl-Pro-Leu-Gly-Pro-D-Arg (Pz peptide), a synthetic collagenase substrate. From 100 ml of the culture supernatant, approximately 1 mg of ColH-his was purified by ammonium sulfate precipitation, IMAC, and high-performance liquid chromatography on a MonoQ column. When IMAC was performed on chelating Sepharose charged with Zn(2+) instead of Ni(2+), a potential carcinogenic metal, the specific activities against Pz peptide and type I collagen decreased slightly. However, they were comparable to those reported for other recombinant ColHs and a commercial C. histolyticum collagenase preparation, suggesting that this expression system is useful for large-scale preparation of high-grade clostridial collagenases.


Subject(s)
Clostridium histolyticum/enzymology , Clostridium perfringens/metabolism , Gene Expression , Matrix Metalloproteinase 8/genetics , Recombinant Fusion Proteins/genetics , Base Sequence , Clostridium perfringens/genetics , Histidine/genetics , Histidine/metabolism , Matrix Metalloproteinase 8/chemistry , Matrix Metalloproteinase 8/isolation & purification , Matrix Metalloproteinase 8/metabolism , Molecular Sequence Data , Oligopeptides/genetics , Oligopeptides/metabolism , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism
14.
Nat Protoc ; 2(7): 1802-10, 2007.
Article in English | MEDLINE | ID: mdl-17641648

ABSTRACT

Here, we provide a detailed protocol for the single protein production (SPP) system, which is designed to produce only a single protein of interest in living Escherichia coli cells. Induction of MazF, an mRNA interferase that cleaves RNA at ACA nucleotide sequences, results in complete cell growth arrest. However, if mRNA encoding a protein of interest is engineered to be devoid of ACA base triplets and is induced at 15 degrees C using pCold vectors in MazF-expressing cells, only the protein from this mRNA is produced at a yield of 20-30% of total cellular protein; other cellular protein synthesis is almost completely absent. In theory, any protein can be produced by the SPP system. Protein yields are typically unaffected even if the culture is condensed up to 40-fold, reducing the cost of protein production by up to 97.5%. The SPP system has a number of key features important for protein production, including high-yield and prolonged production of isotope-labeled protein at a very high signal-to-noise ratio. The procedure can be completed in 7 d after cloning of an ACA-less target gene into the expression system.


Subject(s)
Escherichia coli Proteins/genetics , Escherichia coli/metabolism , Amino Acid Sequence , Base Sequence , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/isolation & purification , Genes, Bacterial
15.
J Biol Chem ; 281(49): 37559-65, 2006 Dec 08.
Article in English | MEDLINE | ID: mdl-17020876

ABSTRACT

We developed a new bacterial expression system that utilizes a combination of attributes (low temperature, induction of an mRNA-specific endoribonuclease causing host cell growth arrest, and culture condensation) to facilitate stable, high level protein expression, almost 30% of total cellular protein, without background protein synthesis. With the use of an optimized vector, exponentially growing cultures could be condensed 40-fold without affecting protein yields, which lowered sample labeling costs to a few percent of the cost of a typical labeling experiment. Because the host cells were completely growth-arrested, toxic amino acids such as selenomethionine and fluorophenylalanine were efficiently incorporated into recombinant proteins in the absence of cytotoxicity. Therefore, this expression system using Escherichia coli as a bioreactor is especially well suited to structural genomics, large-scale protein expressions, and the production of cytotoxic proteins.


Subject(s)
Bioreactors , Escherichia coli/metabolism , Recombinant Proteins/biosynthesis , Bioreactors/microbiology , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Endoribonucleases/genetics , Endoribonucleases/metabolism , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Gene Expression , Genes, Bacterial , Genetic Vectors , Nitrogen Isotopes , Plasmids/genetics , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Selenomethionine/metabolism , p-Fluorophenylalanine/metabolism
16.
Curr Opin Biotechnol ; 17(4): 347-52, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16828276

ABSTRACT

An ultimate goal for any protein production system is to express only the protein of interest without producing other cellular proteins. To date, there are only two established methods that will allow the successful expression of only the protein of interest: the cell-free in vitro protein synthesis system and the in vivo single-protein production (SPP) system. Although single-protein production can be achieved in cell-free systems, it is not easy to completely suppress the production of cellular proteins during the production of a protein of interest in a living cell. However, the finding of a unique sequence-specific mRNA interferase in Escherichia coli led to the development of the SPP system by converting living cells into a bioreactor that produces only a single protein of interest without producing any cellular proteins. This technology not only provides a new high expression system for proteins, but also offers a novel avenue for protein structural studies.


Subject(s)
Biotechnology/methods , Recombinant Proteins/biosynthesis , Animals , Cell-Free System/metabolism , Escherichia coli/drug effects , Escherichia coli/genetics , Escherichia coli/metabolism , Humans , Reticulocytes/metabolism
17.
Mol Cell ; 18(2): 253-61, 2005 Apr 15.
Article in English | MEDLINE | ID: mdl-15837428

ABSTRACT

We designed a single-protein production (SPP) system in living E. coli cells that exploits the unique properties of MazF, a bacterial toxin that is an ssRNA- and ACA-specific endoribonuclease. In effect, MazF functions as an "mRNA interferase," because it efficiently and selectively degrades all cellular mRNAs in vivo, resulting in a precipitous drop in total protein synthesis. Concomitant expression of MazF and a target gene engineered to encode an ACA-less mRNA results in sustained and high-level (up to 90%) target expression in the virtual absence of background cellular protein synthesis. Remarkably, target synthesis continues for at least 4 days, indicating that cells retain transcriptional and translational competence despite their growth arrest. SPP technology works well for E. coli (soluble and membrane), yeast, and human proteins. This expression system enables unparalleled signal to noise ratios that should dramatically simplify structural and functional studies of previously intractable but biologically important proteins.


Subject(s)
Endoribonucleases/metabolism , Escherichia coli Proteins/metabolism , Escherichia coli/metabolism , Protein Biosynthesis , RNA, Messenger/metabolism , Amino Acid Sequence , Bacterial Toxins/metabolism , Endoribonucleases/genetics , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Exotoxins/chemistry , Exotoxins/genetics , Exotoxins/metabolism , Humans , Molecular Sequence Data , Nuclear Magnetic Resonance, Biomolecular , Sequence Homology, Amino Acid , Temperature , Transformation, Genetic
18.
J Biol Chem ; 279(20): 20678-84, 2004 May 14.
Article in English | MEDLINE | ID: mdl-15024022

ABSTRACT

In Escherichia coli, programmed cell death is mediated through the system called "addiction module," which consists of a pair of genes encoding a stable toxin and a labile antitoxin. The pemI-pemK system is an addiction module present on plasmid R100. It helps to maintain the plasmid by post-segregational killing in E. coli population. Here we demonstrate that purified PemK, the toxin encoded by the pemI-pemK addiction module, inhibits protein synthesis in an E. coli cell-free system, whereas the addition of PemI, the antitoxin against PemK, resumes the protein synthesis. Further studies reveal that PemK is a sequence-specific endoribonuclease that cleaves mRNAs to inhibit protein synthesis, whereas PemI blocks the endoribonuclease activity of PemK. PemK cleaves only single-stranded RNA preferentially at the 5' or 3' side of the A residue in the "UAH" sequences (where H is C, A, or U). Upon induction, PemK cleaves cellular mRNAs to effectively block protein synthesis in E. coli. The pemK homologue genes have been identified on the genomes of a wide range of bacteria. We propose that PemK and its homologues form a novel endoribonuclease family that interferes with mRNA function by cleaving cellular mRNAs in a sequence-specific manner.


Subject(s)
DNA-Binding Proteins/metabolism , Endoribonucleases/metabolism , Escherichia coli Proteins/metabolism , Escherichia coli/genetics , Gene Expression Regulation, Bacterial/genetics , RNA, Messenger/genetics , Base Sequence , DNA Primers , DNA-Binding Proteins/genetics , Endoribonucleases/genetics , Escherichia coli Proteins/genetics , Kinetics , Protein Biosynthesis/genetics , RNA, Bacterial/chemistry , RNA, Bacterial/genetics , RNA, Messenger/chemistry , Sequence Alignment
19.
J Bacteriol ; 184(19): 5418-25, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12218030

ABSTRACT

Phosphatidylglycerol, the most abundant acidic phospholipid in Escherichia coli, is considered to play specific roles in various cellular processes that are essential for cell viability. A null mutation of pgsA, which encodes phosphatidylglycerophosphate synthase, does indeed confer lethality. However, pgsA null mutants are viable if they lack the major outer membrane lipoprotein (Lpp) (lpp mutant) (S. Kikuchi, I. Shibuya, and K. Matsumoto, J. Bacteriol. 182:371-376, 2000). Here we show that Lpp expressed from a plasmid causes cell lysis in a pgsA lpp double mutant. The envelopes of cells harvested just before lysis could not be separated into outer and inner membrane fractions by sucrose density gradient centrifugation. In contrast, expression of a mutant Lpp (LppdeltaK) lacking the COOH-terminal lysine residue (required for covalent linking to peptidoglycan) did not cause lysis and allowed for the clear separation of the outer and inner membranes. We propose that in pgsA mutants LppdeltaK could not be modified by the addition of a diacylglyceryl moiety normally provided by phosphatidylglycerol and that this defect caused unmodified LppdeltaK to accumulate in the inner membrane. Although LppdeltaK accumulation did not lead to lysis, the accumulation of unmodified wild-type Lpp apparently led to the covalent linking to peptidoglycan, causing the inner membrane to be anomalously anchored to peptidoglycan and eventually leading to lysis. We suggest that this anomalous anchoring largely explains a major portion of the nonviable phenotypes of pgsA null mutants.


Subject(s)
Bacterial Outer Membrane Proteins/metabolism , Carrier Proteins/metabolism , Cell Membrane/metabolism , Escherichia coli Proteins/metabolism , Escherichia coli/growth & development , Lipoproteins , Phosphatidylglycerols/metabolism , Transferases (Other Substituted Phosphate Groups)/genetics , Anti-Bacterial Agents/pharmacology , Bacterial Outer Membrane Proteins/genetics , Carrier Proteins/genetics , Cell Membrane/chemistry , Detergents/pharmacology , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Proteins/genetics , Mass Spectrometry , Mutation , Phospholipids/analysis , Transferases (Other Substituted Phosphate Groups)/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...